Yuvraj

AstraZeneca oncology portfolio strengthened as MedImmune acquisition of Spirogen boosts antibody-drug conjugate capability

AstraZeneca today announced that MedImmune, its global biologics research and development arm, has acquired Spirogen, a privately-held biotech company focused on antibody-drug conjugate technology...

Nosopharm receives EUR 870,000 (USD 1.18 million) to help combat antibiotic resistance

Nosopharm specializes in the research and development of new anti-infective drugs, today announces that it has secured funding of EUR 870,000 (USD 1.18 million)....

2013 Utah Life Science Summit Features Top State and National Leaders, Unrivalled Networking Opportunities

BioUtah today released the agenda for the 2013 Utah Life Science Summit Utah’s premier life science event which will be held all day November...

Lannett Announces Proposed Public Offering of Common Stock

Lannett Company Inc. today announced that it and certain selling stockholders intend to offer shares of the Company’s common stock in an underwritten public...

Cancer Vaccine Company DCPrime and Janssen To Collaborate on Potential New Therapy

Cancer vaccine company DCPrime BV today announced that it has entered into a research and optional license agreement with Janssen Pharmaceuticals Inc. The collaboration...

Human skin wound dressings to treat cutaneous ulcers

Researchers from Université Laval's Faculty of Medicine and CHU de Québec have shown that it is possible to treat venous ulcers unresponsive to conventional...

Marshall, Gerstein & Borun Named Patent Strategy and Management Team of the Year by LMG Life Sciences

Marshall Gerstein & Borun LLP an intellectual property law firm was recognized as Patent Strategy and Management: Team of the Year by LMG Life...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read